Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials. Through its diverse experience and extensive industry network, they are building Medicus into a leading pharmaceutical holding company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, they identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. They look into opportunities across all therapeutics areas where an unmet need exists for improved patient safety and efficacy. Medicus is actively exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Its portfolio of companies includes Skinject, Inc.
Subscribe to receive latest updates from the council
